Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

BioExx Specialty Proteins Ltd BIXZF

Healthcare Biotechnology
"Bioexx Specialty Proteins Inc is engaged in the development and commercialization of processing technologies, for use in the extracting various active ingredients from organic and inorganic materials. The company's primary focus is on the production of proteins from canola and other oilseed feedstocks. Its products include Isolexx, a protein isolate for use in bakery products, meat products, vegetarian food products and meat analogues, and nutritional and protein bars, drinks, and supplements;


GREY:BIXZF - Post by User

BioExx Specialty Proteins Ltd
Bullboard Posts
User Avatar Image
(0)
•••
Comment by Kantenahon Aug 16, 2010 5:16pm
455 Views
Post# 17354934

RE: RE: RE: Update

RE: RE: RE: UpdateIt is clear that BXI management could not have waited longer before initiating the PP.  All things considered, 1.95 was a good price.  The questions now are:

1. How long will the $30M+ last?
 2. Will revenues from isolate production arrive in time to avoid more severe dilution in the future?

My guess is that one more round of financing will be required to complete Minot.  Hopefully, they get some revenues from Saskatoon and some funding from US governments so that the financing will not need to be large.
 
Only time will tell.

-K   
Bullboard Posts
Dealroom for high-potential pre-IPO opportunities